FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: November 30, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Gao Yan

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/22/2012 

3. Issuer Name and Ticker or Trading Symbol

AMERICAN ORIENTAL BIOENGINEERING INC [AOB]

(Last)        (First)        (Middle)

C/O AOB, INC. 1 LIANSHUIHE FIRST AVE, BEIJING E-TOWN ECONOMIC & TECH AREA

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Chief Accounting Officer /

(Street)

BEIJING, CHINA, F4 100176       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $0.001   6400   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase Common Stock   8/20/2011   8/20/2017   Common Stock   4000   $8.54   D    
Options to purchase Common Stock   11/25/2011   11/25/2017   Common Stock   12000   $4.95   D    
Options to purchase Common Stock   4/10/2011   4/10/2019   Common Stock   2000   $4.01   D    

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Gao Yan
C/O AOB, INC. 1 LIANSHUIHE FIRST AVE
BEIJING E-TOWN ECONOMIC & TECH AREA
BEIJING, CHINA, F4 100176


Chief Accounting Officer

Signatures
/s/ Yan Gao 3/5/2012
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
American Oriental Bioengineering, Inc. (NYSE:AOB)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 American Oriental Bioengineering, Inc. 차트를 더 보려면 여기를 클릭.
American Oriental Bioengineering, Inc. (NYSE:AOB)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 American Oriental Bioengineering, Inc. 차트를 더 보려면 여기를 클릭.